Shopping Cart
Remove All
Your shopping cart is currently empty
CTSLCTSB-IN-1 (Compound212-148) is a dual-specificity inhibitor targeting the host virus spike cleavage proteins CTSL/CTSB and TMPRSS2, with IC50 values of 2.13/64.07 nM and 1.38 μM, respectively. By inhibiting the cleavage of viral spike proteins, CTSLCTSB-IN-1 obstructs two critical entry pathways of the SARS-CoV-2 virus, making it useful for anti-SARS-CoV-2 research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | CTSLCTSB-IN-1 (Compound212-148) is a dual-specificity inhibitor targeting the host virus spike cleavage proteins CTSL/CTSB and TMPRSS2, with IC50 values of 2.13/64.07 nM and 1.38 μM, respectively. By inhibiting the cleavage of viral spike proteins, CTSLCTSB-IN-1 obstructs two critical entry pathways of the SARS-CoV-2 virus, making it useful for anti-SARS-CoV-2 research. |
| In vitro | CTSLCTSB-IN-1 demonstrates significant antiviral activity in Calu-3 cells infected with clinically isolated SARS-CoV-2 δ or omicron BA.2 strains at concentrations of (10 -3 -10 5 nM, 1h). |
| Formula | C41H47N7O6S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.